Linlin Luo

Linlin Luo has extensive experience in bioanalytical and immunogenicity assay development within the pharmaceutical industry. At Merck, Linlin held positions as Sr. Director of Regulated PK & ADA and Director of Regulated Ligand Binding Based Immunogenicity and PK Assay Group, focusing on developing ligand binding assays to support biotherapeutic development. Linlin's role as a Principal Scientist involved overseeing the development and validation of bioanalytical assays across various clinical phases. Prior experience at Bristol-Myers Squibb included oversight of preclinical and clinical method development. Earlier roles at Medarex Inc. involved leading the development of immunogenicity assays, while initial research positions at Johnson & Johnson and Columbia University Medical Center concentrated on cellular assays and protein expression. Linlin holds a Ph.D. in Biochemistry from The Graduate Center, City University of New York.